Streetbeat News

Analyst Ratings

COIN

Investors are showing a bullish stance on Coinbase Glb (NASDAQ:COIN) with significant options trades detected. The sentiment is mixed with 41% bullish and 36% bearish. The stock is currently trading at $157.1, down by 0.86%, and an analyst from Barclays has upgraded its rating to Equal-Weight with a price target of $169.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:46 pm

TTD

Trade Desk (NASDAQ:TTD) has seen a surge in unusual options trading activity, with a mix of bullish and bearish sentiment. The options trades suggest a price range of $60 to $140. Analysts have mixed ratings, with price targets ranging from $110 to $135. The stock is currently trading at $101.49, up 1.79%.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:15 pm

AMAT

Deep-pocketed investors are showing a bullish sentiment towards Applied Materials (NASDAQ:AMAT) with significant options activity. The options scanner highlighted 12 unusual activities, with 58% bullish sentiment. Analysts have set an average price target of $252.0 for AMAT.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:15 pm

PM

Philip Morris Intl (NYSE:PM) has seen unusual options activity, with a significant number of bullish calls, suggesting potential positive movement. Analysts maintain mostly positive ratings, with a consensus target price of $131.4. The stock is currently trading at $126.63.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:01 pm

MEDP

Analysts have mixed ratings for Medpace Holdings (NASDAQ:MEDP), with recent adjustments showing a decline in average price targets. Despite this, Medpace demonstrates strong financial health with positive revenue growth, high net margins, and efficient debt management.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:01 pm

FTRE

Analysts have mixed ratings for Fortrea Holdings (NASDAQ:FTRE), with a recent trend of lowering price targets. The average 12-month price target is now $25.1, down from $30.67. Fortrea, a contract research organization, faces challenges with declining revenue and below-average ROE and ROA, but maintains a strong net margin and healthy debt management.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 7:00 pm

CVS

CVS Health Corporation shares are trading lower following the Trump-Harris debate, which has increased uncertainty in the healthcare sector. Analysts have mixed opinions, with recent downgrades and varied price targets. Options trading shows mixed sentiment among traders.

Portfolio Pulse from Vaishali Prayag

September 11, 2024 | 6:52 pm

SNOW

Investors are showing significant interest in Snowflake (NYSE:SNOW) options, with a majority leaning bullish. The options activity suggests a potential price range of $100 to $170. Analysts have mixed ratings, with a consensus target price of $155.4.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 6:46 pm

TSLA

Deutsche Bank analyst Edison Yu has reinstated coverage of Tesla with a Buy rating and a $295 price target, highlighting Tesla's potential to reshape industries like autonomous driving, energy storage, and robotics. Tesla's Robotaxi Day on Oct. 10 is seen as a major catalyst.

Portfolio Pulse from Chris Katje

September 11, 2024 | 6:43 pm

SUPN

Piper Sandler downgraded Supernus Pharmaceuticals (NASDAQ:SUPN) due to slower-than-expected prescription growth for its ADHD drug, Qelbree. Despite a 92% increase in Qelbree's net sales in Q2 2024, future growth is expected to be modest. Piper adjusted its price target for SUPN from $41 to $36.

Portfolio Pulse from Vandana Singh

September 11, 2024 | 6:38 pm